AblaCare: Infertility Treatment Made Safer

article image
ARTICLE SUMMARY:

Polycystic Ovary Syndrome (PCOS) is the leading cause of female infertility and the most frequently occurring endocrine disorder in women. AblaCare, a recent addition to medtech accelerator MD Start‘s portfolio of therapeutic device companies, is introducing a new device that treats PCOS infertility using RF ablation technology to replicate the effects of laparoscopic ovarian drilling with a safer and less invasive, office-based procedure.

Infertility in women can be a devastating condition that profoundly affects countless lives.

×



This article is restricted to subscribers only.

Sign in to continue reading.

Questions?

We're here to help! Please contact us at: